Product
Supplier
Encyclopedia
Inquiry
Home > Pharmaceutical Intermediates > Bulk Drug Intermediates > Retatrutide for Sale > Wholesale Retatrutide Peptide Powder Retatrutide Factory direct sales
Wholesale Retatrutide Peptide Powder Retatrutide Factory direct sales buy - large image1
Wholesale Retatrutide Peptide Powder Retatrutide Factory direct sales buy - image1
Wholesale Retatrutide Peptide Powder Retatrutide Factory direct sales buy - image2
Wholesale Retatrutide Peptide Powder Retatrutide Factory direct sales buy - image3
Wholesale Retatrutide Peptide Powder Retatrutide Factory direct sales buy - image4
Wholesale Retatrutide Peptide Powder Retatrutide Factory direct sales buy - image5
Wholesale Retatrutide Peptide Powder Retatrutide Factory direct sales buy - image6

Wholesale Retatrutide Peptide Powder Retatrutide Factory direct sales

TDS 7465 Inquiries

Unit Price:

$65.0/UNIT FOB

Get Latest Price
CAS No.:

2381089-83-2

Grade:

Pharmaceutical Grade

Content:

99%

Port:

GZ

Brand:

CaoQuan

Packaging:

5mg*10vials;10mg*10vials;20mg*10vials;10vials/box

Sample Available:

Yes

Price valid:

2026-08-21 ~ 2026-11-19

Company Type:
Trader
Location:
China
Payment Terms:
TT against copy of documents,L/C,TT against B/L draft before shipment,100% TT in advance
Average Lead Time:
1 days
Qualification:
Main Products:

Cagrilintide,Tirzepatide,Semaglutide,Retatrutide,NAD+,Melatonine

  • Product Details

  • Seller Information

  • Inquiry History

  • Description

    ales manager:Bella
    whatsapp:+852 5715 0533
    Email: bl_xtcaoquan@163.com

    sincerely look forward to your inquiries about our products.

    ales manager:Bella
    whatsapp:+852 5715 0533
    Email: bl_xtcaoquan@163.com


      P roduct Detail  


    Tirzepatide (LY3298176) is a dual glucose-dependentpolypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist that is being developed for the treatment of type 2 diabetes. Tirzepatide (LY3298176) shows significantly better efficacy with regard to glucose control and weight loss than do Dulaglutide.

    Tirzepatide, also known as LY 3298176, is a dual glucose-dependent polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist. Tirzepatide has a greater affinity to GIP receptors than to GLP-1 receptors, and this dual agonist behavior has been shown to produce greater reductions of hyperglycemia compared to a selective GLP-1 receptor agonist. Signaling studies reported that tirzepatide mimics the actions of natural GIP at the GIP receptor. Tirzepatide was approved for improving blood sugar control in adults with type 2 diabetes, as an addition to diet and exercise.

    FAQ:

    Is tirzepatide available for weight loss?

    It's also FDA approved for chronic weight management in adults with or without diabetes. Along with diet and exercise, tirzepatide can lead to significant weight loss — an average of 15% to 20% (34 lbs to 48 lbs). But tirzepatide for weight loss is only recommended for people who meet certain BMI criteria


    How fast do you lose weight on tirzepatide?

    How quickly you lose weight depends on factors like lifestyle habits, diet, activity level, age, and other medications you may be taking. However, most people who follow a healthy diet and exercise routine begin reporting some weight loss within a month to two months of starting the medication.


    Is tirzepatide safe to take?

     Tirzepatide, as a weight loss drug, significantly reduces BMI, waist circumference and body weight while gastrointestinal adverse reactions need to be vigilant. Overall, its efficacy is significant and its safety is high.

    Items Specifications
    Product name Tirzepatide
    Appearance White powder
    CAS No. 2023788-19-2
    Purity 99%
    Function Weight loss

    Shop Weight Loss Peptide Powder Factory Supply Tirzepatide 5mg 10mg  20mg 30mg-Detailed Image 1 Shop Weight Loss Peptide Powder Factory Supply Tirzepatide 5mg 10mg  20mg 30mg-Detailed Image 2 Shop Weight Loss Peptide Powder Factory Supply Tirzepatide 5mg 10mg  20mg 30mg-Detailed Image 3


       Product Function   


    The addition of GIP which anatagonizes the central effects of GLP-1 to cause nausea is designed to improve tolerability and also allow for more aggressive dosing with increased systemic exposure. A recent post-hoc analysis showed significantly decreased NASH-related biomarkers and increased adiponectin in patients with T2DM

      The weight-reducing actions of the GIPR-GLP1R co-agonist tirzepatide.Considerable interest is focused on the mechanisms of action of tirzepatide, a highly effective GIPR-GLP1R co-agonist that produces superior reductions in HbA1c and body weight, relative to that achieved with 1 mg once weekly of semaglutide in people with T2D. The GIPR is expressed in multiple regions of the mouse and human brain, in subsets of neurons and glial cells, with some hypothalamic and hindbrain cells exhibiting co-expression of the GIPR and GLP1R. Chemogenetic activation of GIPR + cells in the mouse hypothalamus acutely reduced food intake; however, co-administration of exendin-4 did not produce an additive reduction of food intake when compared to either intervention alone.

      Therapy with tirzepatide, 5-15 mg once weekly produces 8-12% body weight reduction in people with T2D, prompting ongoing development of tirzepatide as a weight loss agent for people with overweight or obesity. The importance of GIP for the weight loss properties of tirzepatide in humans is uncertain; however, tirzepatide failed to reduce body weight in Glp1r−/- mice, implicating a dominant role for the GLP1R in the weight loss observed with this agent. Glucose-dependent polypeptide (GIP) has been shown to reduce the extent of aversive responses induced by GLP-1 in mice and rats and decrease nausea and vomiting in the shrew.

    Product Application 

    • 1.Helps slow food leaving your stomach
    • 2.Helps prevent your liver from making too much sugar
    • 3.Helps the pancreas produce more insul when your blood sugar levels are high
    • 4.Can help control blood glucose
    • 5.Can reduce hyperglycemia, especially after meals
    • 6.Can reduce fasting insul and fasting glucose
    • 7.Can reduce hemoglobin A1c
    • 8.Can decrease appetite and caloric intake, while inhibiting weight gain
    • 9.Has been shown to lower triglyceride levels and oxidative stress from high LDL
    • Shop Weight Loss Peptide Powder Factory Supply Tirzepatide 5mg 10mg  20mg 30mg-Detailed Image 4


    Company Profile  


    Changsha Caoquan Technology Co., Ltd. is a high-tech company specializing in the research and development and production of polypeptide drugs. The company has an advanced industrial chain, covering the research and development, approval and industrialization of peptide raw materials and preparations. Its products include innovative drugs, raw materials, enzymes used in medicine and green synthesis industry, functional peptides and protein products.
    Our core strengths are advanced polypeptide technology, strict quality control (conforming to cGMP standards), professional R&D team, and end-to-end solutions from raw materials to finished products.
    We are committed to providing customers with high-quality and high-value products and services and have established a good reputation in the global market. With excellent product quality, logistics service and customer-centered business philosophy, our products have been exported to more than 100 countries.
    Changsha Cao Quan is willing to maintain cooperative relations with old and new friends and create a better future together!Shop Weight Loss Peptide Powder Factory Supply Tirzepatide 5mg 10mg  20mg 30mg-Detailed Image 5 Shop Weight Loss Peptide Powder Factory Supply Tirzepatide 5mg 10mg  20mg 30mg-Detailed Image 6


    Why choose us?  


    1. Higher quality products (>=99% purity) for most of peptides and raws. Quality Guaranteed: Many HPLC test reports are available (Janoshik).

    2. Domestic warehouses and fast delivery.

    3. Ship worldwide with safe and secure lines: 100% delivery guaranteed. No worry about Customs issues.

    4. Special Service: Drop-shipping if need.

    5. Cheapest prices in the market, unbeatable!

    6. Many payment options: Paypal, bank transfer, alipay, wechat, bitcoin, USDT. Shop Weight Loss Peptide Powder Factory Supply Tirzepatide 5mg 10mg  20mg 30mg-Detailed Image 7



      Product image  


    Shop Weight Loss Peptide Powder Factory Supply Tirzepatide 5mg 10mg  20mg 30mg-Detailed Image 8 Shop Weight Loss Peptide Powder Factory Supply Tirzepatide 5mg 10mg  20mg 30mg-Detailed Image 9 Shop Weight Loss Peptide Powder Factory Supply Tirzepatide 5mg 10mg  20mg 30mg-Detailed Image 10

    If you have any needs, please contact us in a timely manner.

    ales manager:Bella
    whatsapp:+852 5715 0533
    Email: bl_xtcaoquan@163.com

    sincerely look forward to your inquiries about our products.

    ECHEMI Editorial Reference
    Retatrutide is a novel triple agonist peptide of the glucagon receptor (GCGR), glucose-dependent insulinotropic polypeptide receptor (GIPR) and glucagon-like peptide-1 receptor (GLP-1R). Retatrutide inhibits human GCGR, GIPR and GLP-1R with EC50 values of 5.79, 0.0643 and 0.775 nM, respectively and mouse GCGR, GIPR, and GLP-1R with EC50 values of 2.32, 0.191 and 0.794 nM, respectively. It is an important tool for obesity research.Retatrutide potently activates the GLP-1R signaling pathway to stimulate glucose-dependent insulin secretion through activity at the GIP receptor (GIPR) or the GLP-1R.Retatrutide is a synthetic peptide with glucose-lowering effects. It is an antidiabetic agent against type 2 diabetes (T2D), stimulating insulin and suppressing glucagon secretion in a glucose-dependent manner.Retatrutide was also shown to delay gastric emptying, lower fasting and postprandial glucose concentration, decrease food intake and reduce body weight in patients with type 2 diabetes.
    Retatrutide (LY-3437943) was discovered by the American pharmaceutical company Eli Lilly and Company. It is a triple glucagon hormone receptor agonist (GLP-1, GIP, and GCGR receptors) for obesity. The 2024 Lasker~DeBakey Clinical Medical Research Award has been given to Joel Habener and Svetlana Mojsov for their discovery of a new hormone GLP-1(7-37) and to Lotte Knudsen for her role in developing sustained acting versions of this hormone as a treatment for obesity.

    Certificates
    • Wholesale Retatrutide Peptide Powder Retatrutide Factory direct sales Certificates 1 TDS

    Basic Info
    Product Name:

    Retatrutide

    Other Name:

    Retatrutide;GIPR/GLP-1R;LY3437943Retatrutide;Retalutide;Retatrutide (sodium salt);Retatrutide RT5;retatrutide 5mg;Retatratide

    CAS No.:

    2381089-83-2

    InChIKeys:

    MLOLQJNKXBNWFW-SAGGEDDASA-N

    Molecular Weight:

    0

    EC Number:

    200-001-8

    Color/Form:

    White lyophilized

    Characteristics
    Water Solubility:

    Soluble in water (5mg/ml).

    Storage Conditions:

    -20°C

    Critical Temperature & Pressure:

    -20°C

    Research
    Class:

    Triple agonist — GCGR, GIPR, GLP-1R

    Status:

    Investigational (Phase 3)

    Mechanism:

    Simultaneously activates glucagon receptor (GCGR), glucose-dependent insulinotropic polypeptide receptor (GIPR), and glucagon-like peptide-1 receptor (GLP-1R). Engineered from the native GIP backbone with amino acid substitutions to confer GCGR and GLP-1R activity.

    EC50 (Human GCGR):

    5.79 nM

    EC50 (Mouse GIPR):

    0.191 nM

    EC50 (Mouse GLP1R):

    0.794 nM

    EC50 (Mouse GCGR):

    2.32 nM

    EC50 (Human GLP1R):

    0.775 nM

    EC50 (Human GIPR):

    0.0643 nM

    Source:

    Jastreboff AM, et al. N Engl J Med. 2023;389(6):514-526.DOI

    Clinical Development:

    NCT04881760; NCT05882045; NCT06354660

    References
    ChEMBL:

    CHEMBL5095485

    DrugBank:

    DB18993

    KEGG DRUG:

    D12430

    PubChem:

    PubChem

    Disclaimer:

    Retatrutide is an investigational compound not yet approved by FDA or EMA. This listing is for industrial and laboratory research use only. Product information on ECHEMI is provided for sourcing and specification reference. It is not medical advice, a clinical recommendation, or an approved therapy description. Always verify regulatory status, purity, and intended use with the supplier and applicable authorities before purchase or use.

  • Seller Information
    Business Type:

    Trader

    Main Products:

    Cagrilintide,Tirzepatide,Semaglutide,Retatrutide,NAD+,Melatonine

    Location:

    Room 102, No. 60-20, Gongnong Street, Xiangya Road Subdistrict, Kaifu District, Changsha City, Hunan Province, China

    Payment Terms:

    TT against copy of documents,L/C,TT against B/L draft before shipment,100% TT in advance

    Average lead Time:

    1 days

    Total Annual Revenue:

    $1 million-$2.5 million

    Total Employees:

    11-50

    Year of Establishment:

    2023

    Company Certificates
    • Changsha Caoquan Biotechnology Co., Ltd.Certificate Certificate
    • Changsha Caoquan Biotechnology Co., Ltd.Certificate Certificate
  • Inquiry History
    7465 Inquiries
    Country Product Purchase Quantity Date Posted
    United States

    Tesa

    2 MG Oct 25, 2026
    Colombia

    Retatrutide

    15 MG Oct 25, 2026
    United States

    Retatrutide

    10 G Oct 25, 2026
    Canada

    Retatrutide

    1 KG Oct 25, 2026
    United Kingdom

    Retatrutide

    1 G Oct 25, 2026
    Netherlands

    Retatrutide

    10 MG Oct 25, 2026
    Australia

    Retatrutide

    10 MG Oct 25, 2026
    Netherlands

    Retatrutide

    20 MG Oct 25, 2026
    Germany

    Retatrutide

    1 KG Oct 25, 2026
    United Kingdom

    Retatrutide

    10 G Oct 25, 2026
    United States

    Retatrutide

    20 MG Oct 25, 2026
    Poland

    Retatrutide

    20 MG Oct 25, 2026
    United States

    Retatrutide

    10 MT Oct 25, 2026
    United States

    Retatrutide

    300 MG Oct 25, 2026
    Germany

    Retatrutide

    1 MT Oct 24, 2026
    Malta

    Retatrutide

    10 MT Oct 24, 2026
    United States

    Retatrutide

    2000 MG Oct 24, 2026
    Australia

    Retatrutide

    100 MT Oct 24, 2026
    Bulgaria

    Retatrutide

    10 PCS Oct 24, 2026
    United States

    retatrutide

    10 MT Oct 24, 2026
    Post an enquiry for this product
pic ×

Scan the QR Code to Share

All products displayed on this website are only for non-medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.

According to relevant laws and regulations and the regulations of this website, units or individuals who purchase hazardous materials should obtain valid qualifications and qualification conditions.

The information shown above is provided by the enterprise itself, and the authenticity, accuracy and legitimacy of the content are the responsibility of the publishing company. ECHEMI does not bear any guarantee responsibility for this. Please be aware that risks in internet transactions objectively exist.

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.